Shares of bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $121.92 and traded as high as $125.44. bioMérieux shares last traded at $125.44, with a volume of 1 shares trading hands.
bioMérieux Price Performance
The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10. The firm has a 50 day moving average price of $121.92 and a 200-day moving average price of $114.07.
bioMérieux Company Profile
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Recommended Stories
- Five stocks we like better than bioMérieux
- 3 Fintech Stocks With Good 2021 Prospects
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is the Shanghai Stock Exchange Composite Index?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20221104121215&h=45&w=95&zc=2){kind=logo}
